Carvykti Archives -

Bristol-Myers Squibb is on course to move its BCMA-targeting CAR-T therapy further up the treatment pathway in multiple

Abecma hits the mark in earlier-stage multiple myeloma

https://pharmaphorum.com/news/abecma-hits-the-mark-in-earlier-stage-multiple-myeloma/

Johnson & Johnson and Legend Biotech will arrive at next week’s ASCO congress with a new EU approval

J&J, Legend get EU nod for myeloma CAR-T Carvykti

https://pharmaphorum.com/news/jj-legend-get-eu-nod-for-myeloma-car-t-carvykti/

Johnson & Johnson is in course for approval of its multiple myeloma CAR-T therapy Carvykti in the EU

CHMP backs J&J’s myeloma CAR-T therapy Carvykti

https://pharmaphorum.com/news/chmp-backs-jjs-myeloma-car-t-therapy-carvykti/

Carvykti